Aiocd Pharma Limited - Company Profile

Q: Who are the current directors of Aiocd Pharma Limited?

The current directors of Aiocd Pharma Limited are Devesh Amubhai Pathak, Jagannath Sakharam Shinde, Ravindra Raigonda Patil, Prasad Waman Danave, Ravindra Bajirao Pawar, Vijay Pandurang Patil, Basavraj Channappa Manure, Jashvant Patel Prahladbhai, Vaijanath Eknath Jagushte, Rinku Rakesh Gadani, Raveendran Balkrishnan.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2006.

2006 Mumbai, Maharashtra, India Active

Last Updated: January 08, 2026

Access Report

About Aiocd Pharma Limited

Aiocd Pharma Limited, a active public limited company, was established on 16 October 2006 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239MH2006PLC165149. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹76.00 Cr and a paid-up capital of ₹27.47 Cr.

Formerly known as Maharashtra Safe Chemists And Distributors Alliance Limited. It upholds a compliant status. Employing 42 professional, Its leadership includes Devesh Amubhai Pathak (Director), Jagannath Sakharam Shinde (Director), Ravindra Raigonda Patil (Cfo). Past directors included Madan Krishnarao Patil, Devesh Amubhai Pathak, Ravindra Manohar Savant. Its latest AGM occurred on 20 December 2024, with the balance sheet filed on 31 March 2024. It is based at 6Th Floor, Corporate Park-Ii, V.N. Purav Marg, Chembur,, Mumbai, Maharashtra, 400071.

Company Details

CIN/LLPIN
U24239MH2006PLC165149
Registration Number
165149
Incorporation Date
16 October 2006
Authorized Capital
₹76.00 Cr
Paid-Up Capital
₹27.47 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 76.00 Cr as on 08-01-2026
Paid Up Capital ₹ 27.47 Cr as on 08-01-2026
Company Age 19 Year, 3 Months
Last Filing with ROC 31 Mar 2024
Revenue Growth **** 11.03% (FY 2023)
Profit Growth **** -9.74% (FY 2023)
Ebitda **** -85.95% (FY 2023)
Net Worth 1.38% (FY 2023)
Total Assets **** 0.93% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Aiocd Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Aiocd Pharma Limited?

Current Directors

Name	Designation	Appointment Date	Status
Devesh Amubhai Pathak	Director	28 Aug 2019	Current
Jagannath Sakharam Shinde	Director	16 Oct 2006	Current
Ravindra Raigonda Patil	Cfo	11 Feb 2022	Current
Prasad Waman Danave	Managing Director	30 Sep 2020	Current
Ravindra Bajirao Pawar	Director	08 Dec 2021	Current
Vijay Pandurang Patil	Director	15 Feb 2019	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	15 Jun 2017	Past
Pramod Abcsdd	Additional Director	30 Sep 2019	Past
Pramod Abcsdd	Director	01 Oct 2019	Past
Pramod Abcsdd	Director	30 Mar 2012	Past
Pramod Abcsdd	Director	19 Mar 2013	Past
Pramod Abcsdd	Director	20 Aug 2014	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aiocd Pharma.

Aiocd Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.03% increase. The company also saw a slight decrease in profitability, with a 9.74% decrease in profit. The company's net worth moved up by a moderate rise of 1.38%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

11.03%

*******

Revenue from Operations

*******

10.51%

*******

Total Assets

*******

0.93%

*******

Profit or Loss

*******

-9.74%

*******

Net Worth

*******

1.38%

*******

EBITDA

*******

-85.95%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aiocd Pharma?

In 2023, Aiocd Pharma had a promoter holding of 1.32% and a public holding of 98.68%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aiocd Pharma?

Aiocd Pharma has a workforce of 42 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Aiocd Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aiocd Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aiocd Pharma

Recent Activity within the Organization

Annual General Meeting

Aiocd Pharma Limited last Annual general meeting of members was held on 20 Dec 2024 as per latest MCA records. was recorded as a recent event.
20 Dec 2024
Balance Sheet

Progress on Aiocd Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
31 Mar 2024
Director Appointment

Jashvant Patel Prahladbhai was appointed as a Director was appointed as a Director on 13 Sep 2023 & has been associated with this company since 2 years 4 months . was recorded as a recent event.
13 Sep 2023
Director Appointment

Vaijanath Eknath Jagushte was appointed as a Director was appointed as a Director on 13 Sep 2023 & has been associated with this company since 2 years 4 months . was recorded as a recent event.
13 Sep 2023
Director Appointment

Progress on Raveendran Balkrishnan was appointed as a Director was appointed as a Director on 13 Sep 2023 & has been associated with this company since 2 years 4 months . was documented.
13 Sep 2023
Director Appointment

The activity Basavraj Channappa Manure was appointed as a Director was appointed as a Director on 02 May 2023 & has been associated with this company since 2 years 9 months . was completed.
02 May 2023

Explore recent activity and updates - View Recent Activity